Navigation Links
Shire plc - Statement re: Media Speculation

DUBLIN, July 11, 2014 /PRNewswire/ --

Not for release, publication or distribution (in whole or in part) in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. 

Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) notes the Bloomberg article this afternoon.  Shire confirms it has held a meeting with representatives of AbbVie.

This statement is being made by Shire without the prior agreement or approval of AbbVie.

A further update will be made when appropriate.  Shareholders are strongly advised to take no action in relation to AbbVie's proposal.  There can be no certainty that any firm offer will be made nor as to the terms on which any firm offer might be made.

A copy of this announcement will be available at  The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Notes to editors 

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.




Stephanie Fagan


FTI Consulting (Media Adviser to the Company) 

Andrew Lorenz (London'/>"/>

SOURCE Shire plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire Launches Online Educational Resource Center for US Patients with Ulcerative Colitis
2. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
3. Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
4. Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
5. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
6. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
7. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
8. Shire Reaches Agreement in Principle With U.S. Government
9. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
10. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
11. Shire Changes its NASDAQ Ticker Symbol to SHPG
Post Your Comments:
(Date:10/8/2015)... WILMINGTON, Del. , Oct. 8, 2015 /PRNewswire/ ... of CRISPR-Cas technologies for genome editing, jointly announced ... DuPont and Caribou have cross-licensed their respective patent portfolios, ... CRISPR-Cas technology applications in major row crops, and ... applications. --> ...
(Date:10/8/2015)... LOUIS , Oct. 8, 2015  Sigma-Aldrich ... the Cerilliant ® brand within its Applied ... new bile acid reference standards product line with ... most routinely tested bile acids and their stable-labeled ... (CRMs) consist of lithocholic acid, taurocholic acid and ...
(Date:10/7/2015)... India , October 8, 2015 /PRNewswire/ ... --> Medical biotechnology accounts for largest ... of bioinformatics in drug discovery and development ... . ... On the basis of applications, the ...
(Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. (OTCQX: ... nutritional ingredients that creates science-based solutions for dietary ... and pharmaceutical products, today announced that the October ... and Founder, is now available for on-demand viewing ... -->   --> ...
Breaking Biology Technology:
... ATLANTA, Oct. 20 GeoVax Labs, Inc. ... "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for ... infectious agents, today announced that it will move its ... of Emory University to Smyrna, Georgia, a northwest suburb ...
... scar Custance from the National Institute for Materials Science in ... Experimental Work in Nanotechnology for his research in atomic-scale precision. ... to more effective catalysts for the production of hydrogen fuel. ... awarded in January 2010 near Palo Alto, California along with ...
... - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: ... endocrine therapy and oncology, announced today that it has ... of common shares and common share purchase warrants in ... Securities Purchase Agreement, the Company will sell to such ...
Cached Biology Technology:
(Date:9/10/2015)... 10, 2015 Report Details ... Selling Opportunities and Revenue Prospects to Help You ... biologics, especially new drug classes? Get the latest ... with exclusive market data and industry knowledge, benefitting ... results, opportunities and sales predictions. Visiongain,s new ...
(Date:9/8/2015)... Sept. 8, 2015   TREW Marketing and ... survey, Smart Marketing for Engineers TM : Content ... professionals reveals insightful findings about engineers, preferences for online ... content engineers most value and trust, and where they ... targeting technical audiences grapple with how to best implement ...
(Date:9/1/2015)... Sept. 1, 2015  Automation and pre-processing are ... passenger screening. This is the first step toward ... will become unintrusive. An assortment of portal scanners, ... background investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
Breaking Biology News(10 mins):
... an outbreak of the bee infection American foulbrood in Jersey, ... diseases such as European foulbrood and the Varroa ... the method also allows scientists to simulate various disease control ... used two sets of data gathered two months apart during ...
... , ,A new EU project, METSY, develops and ... lipid metabolism is connected to psychotic disorders and ... , The overall objective is to identify, prioritize ... have diagnostic potential for prediction and monitoring psychotic ...
... (16 SEPTEMBER 2013)Kenyan farmers and agriculture officials need ... maize production as climate change threatens to make ... for cultivation while simultaneously making others more maize-friendly, ... International Food Policy Research Institute (IFPRI) and the ...
Cached Biology News:
... Mutation Explorer processes up to 48 ... traces. Data input can be from either ... terminator or primer chemistries. The detection parameters ... analyst to analyst consistency. We have ...
... graphic manipulation of DNA sequences and sophisticated ... winning interface design that allows graphic manipulation ... sophisticated drawing capabilities for Mac and Windows ... Mapping Software" by the Biotechnology Software and ...
... Quality ISO 9001:2000 Certified USDA ... Precedures Validated, SOP's Training AALAS ... for All Procedures GLP Documentation Upon Request ... stop shopping point for all your custom ...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
Biology Products: